A carregar...
Pertuzumab and trastuzumab: the rationale way to synergy
It has now been 15 years since the HER2-targeted monoclonal antibody trastuzumab was introduced in clinical and revolutionized the treatment of HER2-positive breast cancer patients. Despite this achievement, most patients with HER2-positive metastatic breast cancer...
Na minha lista:
| Publicado no: | Anais da Academia Brasileira de Ciências |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Academia Brasileira de Ciências
2016
|
| Assuntos: | |
| Acesso em linha: | https://www.redalyc.org/articulo.oa?id=32746362012 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|